Empirical comparison of structure-based pathway methods.

Area of Science:

• Bioinformatics
• Computational Biology
• Genomics

Background:

• Accurate pathway activity estimation from gene expression profiles is essential for biological insight.
• A lack of comparative performance data hinders the selection of appropriate pathway analysis tools.
• Both gene list-based and structure-based methods exist, but their relative efficacy is not well-established.

Purpose of the Study:

• To evaluate and compare the performance of six different pathway activity estimation methods.
• To provide practical insights into the utility of list-based versus structure-based approaches.
• To assess method performance across diverse biological datasets with varying complexity.

Main Methods:

• Six distinct pathway analysis methods were applied to estimate pathway activities.
• Two case study settings were utilized: renal cell cancer (large expression differences) and type 1 diabetes (subtle expression differences).
• Performance was assessed across multiple datasets within each case study.

Main Results:

• Significant discrepancies in pathway analysis outcomes were observed among the tested methods, even with identical input data.
• Method consistency was generally high across datasets within the cancer study, but methods differed.
• In the more challenging type 1 diabetes study, most methods identified very few significant pathways, highlighting analytical difficulties.

Conclusions:

• The choice of pathway analysis tool significantly impacts results, necessitating careful method selection.
• Structure-based methods and list-based methods exhibit varying performance depending on the biological context and data characteristics.
• The subtle differences in type 1 diabetes expression profiles pose a considerable challenge for current pathway analysis tools.